Neonatal ECMO study of temperature (NEST): a randomized controlled trial.

BACKGROUND: Despite evidence to support the use of extracorporeal membrane oxygenation (ECMO) in defined groups of newborn infants, rates of impairment among survivors remain high. Therapeutic hypothermia has been shown to provide neuroprotection in mature infants exposed to perinatal asphyxia. We h...

Full description

Bibliographic Details
Main Authors: Field, D, Juszczak, E, Linsell, L, Azzopardi, D, Cowan, F, Marlow, N, Edwards, D
Format: Journal article
Language:English
Published: 2013
_version_ 1797103881385148416
author Field, D
Juszczak, E
Linsell, L
Azzopardi, D
Cowan, F
Marlow, N
Edwards, D
author_facet Field, D
Juszczak, E
Linsell, L
Azzopardi, D
Cowan, F
Marlow, N
Edwards, D
author_sort Field, D
collection OXFORD
description BACKGROUND: Despite evidence to support the use of extracorporeal membrane oxygenation (ECMO) in defined groups of newborn infants, rates of impairment among survivors remain high. Therapeutic hypothermia has been shown to provide neuroprotection in mature infants exposed to perinatal asphyxia. We hypothesized that therapeutic hypothermia during ECMO would reduce the proportion of infants with brain injury, and thus later impairment. METHODS: We conducted a randomized trial in the United Kingdom to compare ECMO with cooling (34°C for the first 48 to 72 hours) with standard ECMO (37°C). The primary outcome was the cognitive composite score of the Bayley Scales of Infant and Toddler Development, 3rd edition, at 2 years. Prespecified secondary outcomes included death, neonatal morbidity, and other neurodevelopmental and behavioral outcomes at 2 years. RESULTS: A total of 111 infants were entered into the study, 14 died before 2 years of age (16% who received ECMO with cooling vs 9% who received ECMO alone). Two infants were lost to follow-up, and 8 were unable to complete the full range of tests. For 45 evaluated infants who received ECMO with cooling, mean cognitive scores at 2 years were 88.0 (SD: 16.2) compared with 90.6 (SD: 13.1) for 48 infants receiving ECMO only (difference in means: -2.6; 95% confidence interval: -8.7 to 3.4). The various secondary outcomes were not significantly different between the groups, but most favored ECMO without cooling. CONCLUSIONS: In newborn infants treated by ECMO, the use of mild hypothermia for the first 48 to 72 hours did not result in improved outcomes up to 2 years of age.
first_indexed 2024-03-07T06:26:18Z
format Journal article
id oxford-uuid:f468c23a-ab90-472d-898e-f8d23b56eca3
institution University of Oxford
language English
last_indexed 2024-03-07T06:26:18Z
publishDate 2013
record_format dspace
spelling oxford-uuid:f468c23a-ab90-472d-898e-f8d23b56eca32022-03-27T12:19:36ZNeonatal ECMO study of temperature (NEST): a randomized controlled trial.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f468c23a-ab90-472d-898e-f8d23b56eca3EnglishSymplectic Elements at Oxford2013Field, DJuszczak, ELinsell, LAzzopardi, DCowan, FMarlow, NEdwards, DBACKGROUND: Despite evidence to support the use of extracorporeal membrane oxygenation (ECMO) in defined groups of newborn infants, rates of impairment among survivors remain high. Therapeutic hypothermia has been shown to provide neuroprotection in mature infants exposed to perinatal asphyxia. We hypothesized that therapeutic hypothermia during ECMO would reduce the proportion of infants with brain injury, and thus later impairment. METHODS: We conducted a randomized trial in the United Kingdom to compare ECMO with cooling (34°C for the first 48 to 72 hours) with standard ECMO (37°C). The primary outcome was the cognitive composite score of the Bayley Scales of Infant and Toddler Development, 3rd edition, at 2 years. Prespecified secondary outcomes included death, neonatal morbidity, and other neurodevelopmental and behavioral outcomes at 2 years. RESULTS: A total of 111 infants were entered into the study, 14 died before 2 years of age (16% who received ECMO with cooling vs 9% who received ECMO alone). Two infants were lost to follow-up, and 8 were unable to complete the full range of tests. For 45 evaluated infants who received ECMO with cooling, mean cognitive scores at 2 years were 88.0 (SD: 16.2) compared with 90.6 (SD: 13.1) for 48 infants receiving ECMO only (difference in means: -2.6; 95% confidence interval: -8.7 to 3.4). The various secondary outcomes were not significantly different between the groups, but most favored ECMO without cooling. CONCLUSIONS: In newborn infants treated by ECMO, the use of mild hypothermia for the first 48 to 72 hours did not result in improved outcomes up to 2 years of age.
spellingShingle Field, D
Juszczak, E
Linsell, L
Azzopardi, D
Cowan, F
Marlow, N
Edwards, D
Neonatal ECMO study of temperature (NEST): a randomized controlled trial.
title Neonatal ECMO study of temperature (NEST): a randomized controlled trial.
title_full Neonatal ECMO study of temperature (NEST): a randomized controlled trial.
title_fullStr Neonatal ECMO study of temperature (NEST): a randomized controlled trial.
title_full_unstemmed Neonatal ECMO study of temperature (NEST): a randomized controlled trial.
title_short Neonatal ECMO study of temperature (NEST): a randomized controlled trial.
title_sort neonatal ecmo study of temperature nest a randomized controlled trial
work_keys_str_mv AT fieldd neonatalecmostudyoftemperaturenestarandomizedcontrolledtrial
AT juszczake neonatalecmostudyoftemperaturenestarandomizedcontrolledtrial
AT linselll neonatalecmostudyoftemperaturenestarandomizedcontrolledtrial
AT azzopardid neonatalecmostudyoftemperaturenestarandomizedcontrolledtrial
AT cowanf neonatalecmostudyoftemperaturenestarandomizedcontrolledtrial
AT marlown neonatalecmostudyoftemperaturenestarandomizedcontrolledtrial
AT edwardsd neonatalecmostudyoftemperaturenestarandomizedcontrolledtrial